RELMADA THERAPEUTICS, INC.
For the period ended Dec 31, 2025. Filed Mar 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We do not own any property.
The Company’s corporate headquarters are located at 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, Florida 33134.
Pursuant to a lease agreement, dated August 1, 2021, and renewed for each subsequent year after, the Company leases office space at 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134. Under the 2021 lease agreement the average monthly rent expense was approximately $11,000. For 2024, 2025 and 2026, the renewed lease agreement was for an average monthly rent expense of approximately $7,000, $4,500 and $4,600, respectively.
Beginning on December 1, 2023, the Company leased office space at 12 E 49 th Street, New York, NY 10022 for approximately $12,000 per month, that lease was terminated on May 31, 2024.
Beginning on May 29, 2024, the Company leased office space at 12 E 49 th Street, New York, NY 10022 with monthly rent of approximately $10,500; that lease expired on May 30, 2025 with the Company continuing to lease the space under a month-to-month option.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.